EDGAR Filing Documents for 0001144204-06-022558

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001144204-06-022558

Filing Date

2006-05-25

Accepted

2006-05-25 14:50:32

Documents

Period of Report

2005-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		v044137_20f.htm	20-F	2832211
2		v044137_ex31-1.htm	EX-31.1	10369
3		v044137_ex31-2.htm	EX-31.2	10377
4		v044137_ex32-1.htm	EX-32.1	8265
	Complete submission text file	0001144204-06-022558.txt		2862543

Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000

Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3

XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 000-51310 | Film No.: 06866895
SIC: 2834 Pharmaceutical Preparations